ACP
TMO icon

Aviance Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Aviance Capital Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.15M Sell
14,538
-66
-0.5% -$35.8K 0.84% 24
2025
Q4 		$8.46M Buy
14,604
+51
+0.4% +$28.8K 0.98% 18
2025
Q3 		$7.06M Buy
14,553
+228
+2% +$106K 0.84% 24
2025
Q2 		$5.81M Buy
14,325
+306
+2% +$128K 0.76% 28
2025
Q1 		$6.98M Buy
14,019
+437
+3% +$237K 0.98% 21
2024
Q4 		$7.07M Buy
13,582
+260
+2% +$143K 0.98% 19
2024
Q3 		$8.24M Buy
13,322
+54
+0.4% +$32K 1.09% 20
2024
Q2 		$7.34M Buy
13,268
+225
+2% +$129K 1.04% 16
2024
Q1 		$7.58M Buy
13,043
+2,251
+21% +$1.26M 1.13% 17
2023
Q4 		$5.73M Sell
10,792
-18
-0.2% -$8.71K 1.23% 16
2023
Q3 		$5.47M Sell
10,810
-341
-3% -$182K 1.23% 16
2023
Q2 		$5.82M Buy
11,151
+444
+4% +$240K 1.23% 14
2023
Q1 		$6.17M Sell
10,707
-32
-0.3% -$18K 1.37% 10
2022
Q4 		$5.91M Buy
10,739
+14
+0.1% +$7.42K 1.38% 11
2022
Q3 		$5.44M Sell
10,725
-426
-4% -$238K 1.35% 9
2022
Q2 		$6.06M Buy
11,151
+46
+0.4% +$25.3K 1.35% 8
2022
Q1 		$6.56M Buy
11,105
+71
+0.6% +$40.8K 1.2% 13
2021
Q4 		$7.36M Buy
11,034
+93
+0.9% +$58.1K 1.23% 16
2021
Q3 		$6.25M Sell
10,941
-62
-0.6% -$34K 1.1% 21
2021
Q2 		$5.55M Buy
11,003
+388
+4% +$183K 0.97% 24
2021
Q1 		$4.84M Sell
10,615
-20
-0.2% -$9.55K 0.94% 24
2020
Q4 		$4.95M Buy
10,635
+39
+0.4% +$18.3K 1% 19
2020
Q3 		$4.68M Buy
10,596
+157
+2% +$64.9K 1.05% 20
2020
Q2 		$3.78M Buy
10,439
+904
+9% +$303K 0.93% 23
2020
Q1 		$2.7M Buy
9,535
+84
+0.9% +$26.5K 0.85% 27
2019
Q4 		$3.07M Buy
9,451
+521
+6% +$158K 0.78% 26
2019
Q3 		$2.6M Buy
8,930
+420
+5% +$120K 0.76% 30
2019
Q2 		$2.5M Buy
8,510
+62
+0.7% +$17.1K 0.69% 32
2019
Q1 		$2.31M Sell
8,448
-5
-0.1% -$1.24K 0.66% 29
2018
Q4 		$1.89M Sell
8,453
-753
-8% -$177K 0.66% 35
2018
Q3 		$2.25M Buy
9,206
+290
+3% +$66.7K 0.54% 38
2018
Q2 		$1.85M Sell
8,916
-72
-0.8% -$15.3K 0.53% 47
2018
Q1 		$1.85M Sell
8,988
-89
-1% -$18.7K 0.56% 42
2017
Q4 		$1.72M Buy
9,077
+150
+2% +$28.7K 0.57% 45
2017
Q3 		$1.69M Sell
8,927
-1,900
-18% -$344K 0.57% 44
2017
Q2 		$1.89M Buy
10,827
+350
+3% +$58.8K 0.61% 40
2017
Q1 		$1.61M Sell
10,477
-980
-9% -$150K 0.59% 43
2016
Q4 		$1.62M Sell
11,457
-2,940
-20% -$433K 0.57% 47
2016
Q3 		$2.29M Buy
14,397
+7,057
+96% +$1.09M 0.81% 31
2016
Q2 		$1.08M Buy
7,340
+3,005
+69% +$444K 0.4% 73
2016
Q1 		$614K Hold
4,335
– – 0.21% 115
2015
Q4 		$615K Hold
4,335
– – 0.21% 118
2015
Q3 		$530K Hold
4,335
– – 0.22% 123
2015
Q2 		$563K Hold
4,335
– – 0.21% 136
2015
Q1 		$582K Sell
4,335
-15
-0.3% -$1.93K 0.21% 138
2014
Q4 		$545K Buy
4,350
+15
+0.3% +$1.82K 0.2% 139
2014
Q3 		$528K Buy
4,335
+450
+12% +$54.7K 0.2% 150
2014
Q2 		$458K Hold
3,885
– – 0.18% 153
2014
Q1 		$467K Buy
3,885
+160
+4% +$19K 0.2% 141
2013
Q4 		$415K Buy
3,725
+200
+6% +$19.9K 0.17% 148
2013
Q3 		$325K Buy
+3,525
New +$319K 0.15% 163

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Aviance Capital Partners's TMO Position: Q1 2026 in Review

Aviance Capital Partners reduced its Thermo Fisher Scientific (TMO) stake by 0.45% in Q1 2026, selling an estimated $35.8K and leaving 14,538 shares worth $7.15M. The position accounts for 0.84% of the portfolio, ranked #24.

Aviance Capital Partners first reported a position in TMO in Q3 2013 and has held it in 51 quarters since. The position peaked at $8.46M in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Aviance Capital Partners held 14,538 shares of Thermo Fisher Scientific worth $7.15M as of Q1 2026.
  • Aviance Capital Partners sold 66 Thermo Fisher Scientific shares in Q1 2026, an estimated $35.8K.
  • Thermo Fisher Scientific made up 0.84% of Aviance Capital Partners's portfolio in Q1 2026, its #24 holding.
  • Aviance Capital Partners first reported a position in Thermo Fisher Scientific in Q3 2013 and has held it in 51 quarters since.
  • Aviance Capital Partners's Thermo Fisher Scientific position peaked at $8.46M in Q4 2025.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Aviance Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.